NOSE TO BRAIN DELIVERY: ROLE OF VIRAL AND NON-VIRAL VECTORS FOR NEUROLOGICAL DISORDER-Reference-Cited by-同舟云学术

NOSE TO BRAIN DELIVERY: ROLE OF VIRAL AND NON-VIRAL VECTORS FOR NEUROLOGICAL DISORDER

Published:2021-07-12 Issue:05 Volume:58 Page:7-20
ISSN:0019-462X
Container-title:Indian Drugs
language:
Short-container-title:Ind. Dru.

Author:

Musale Shubham,Giram Prabhanjan,

Abstract

Nose to brain delivery is an alternative and efficient way of delivery of drugs, protein, peptides, DNA, RNA, and plasmids for improved therapeutics in the treatment of neurological disorders. Nanotechnology enables the use of nanocarriers, such as polymer, lipid, and metal-based for delivery of an active agent to targeted site selectively and minimise other systemic side effects. Viral vectors like herpes simplex, adenovirus, and lentivirus are also used for the delivery of genes to the brain with improved transfection efficiency and transduction process. Metal-based nanomaterials such as gold and super magnetic iron oxide nanoparticles, used for theranostic application for brain-related nose to brain delivery, has proven several advantages and are discussed together with their limitations, in this review in detail.

Publisher

Indian Drug Manufacturers' Association (IDMA)

Subject

Drug Discovery,Pharmaceutical Science,Pharmacology

Reference154 articles.

1. 1. Alexande A,Agrawal M, Chougule M.B, Saraf S, Saraf S,Nose-to-brain drug delivery: an alternative approach for effective brain drug targeting, Expectations and Realities of Multifunctional Drug Delivery Systems,2020,1,175-200.

2. 2. Selvaraj K, Gowthamarajan K, Karri V,Nose to brain transport pathways an overview: potential of nanostructured lipid carriers in nose to brain targeting. Artif Cells Nanomed Biotechnol,2018,46,088-95.

3. 3.Noriyasu K,Misa T,Hayoung C,Nobuyuki O,Takamasa I,Rei I, Effect of an Enhanced Nose-to-Brain Delivery of Insulin on Mild and Progressive Memory Loss in the Senescence-Accelerated Mouse, Mol. Pharmaceutics, 2017, 14,916-927.

4. 4.Lochhead J. J,Thorne R. G, Intranasal delivery of biologics to the central nervous system Adv. Drug Delivery Rev, 2012, 64,614– 28.

5. 5.Dhuria, S. V,Hanson L. R,Frey W. H , Intranasal delivery to the central nervous system: mechanisms and experimental considerations, J. Pharm. Sci,2010, 99,1654– 73 .

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances and challenges in gene therapy strategies for pediatric cancer: a comprehensive update;Frontiers in Molecular Biosciences;2024-05-21